Nobleoak LifeASX:NOL 54 9-Day RSI is 51.61 as of Jul. 04, 2026. GuruFocus rates ASX:NOL with a GF Score™ of 54/100 and a GF Value™ of A$1.76 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 593 Insurance companies, Nobleoak Life ranks better than 64.59% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
As of today (2026-07-04), Nobleoak Life's 9-Day RSI is 51.61.
The industry rank for Nobleoak Life's 9-Day RSI or its related term are showing as below:
ASX:NOL's 9-Day RSI is ranked better than 64.59% of 593
companies
in the Insurance industry
Industry Median: 60.52
vs ASX:NOL: 51.61
Nobleoak Life (ASX:NOL) 9-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
Nobleoak Life 9-Day RSI Related Terms
ASX:NOL vs AFL, MET, PRU: 9-Day RSI Comparison
For the Insurance - Life subindustry, Nobleoak Life's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nobleoak Life 9-Day RSI vs Insurance Industry
For the Insurance industry and Financial Services sector, Nobleoak Life's 9-Day RSI distribution charts can be found below:
* The bar in red indicates where Nobleoak Life's 9-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nobleoak Life (ASX:NOL) has a 9-Day RSI of 51.61 as of Jul. 04, 2026. According to the industry distribution chart, Nobleoak Life ranks #210 out of 593 companies in the Insurance industry, placing it in the top 35.4%.
Is Nobleoak Life's 9-Day RSI too high?
Nobleoak Life's current 9-Day RSI is 51.61. The Insurance industry median 9-Day RSI is 60.52. Nobleoak Life's value of 51.61 is 14.7% below this industry median. Based on the distribution chart, Nobleoak Life ranks #210 out of 593 companies in the Insurance industry, which is above the industry midpoint. Overall, Nobleoak Life has a GF Score™ of 54/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Nobleoak Life's 9-Day RSI compare to AFL and MET?
According to the Insurance industry distribution chart, Nobleoak Life ranks #210 out of 593 companies for 9-Day RSI. This puts Nobleoak Life in the upper half of its industry. The industry median 9-Day RSI is 60.52. Nobleoak Life's value of 51.61 is 14.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for an Insurance company?
The median 9-Day RSI among Insurance companies is 60.52, based on 593 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nobleoak Life's current 9-Day RSI of 51.61 is 14.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Insurance industry, the median 9-Day RSI is 60.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nobleoak Life's current 9-Day RSI is 51.61. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nobleoak Life stock overvalued right now?
Based on GuruFocus' analysis, Nobleoak Life (ASX:NOL) is currently considered Modestly Undervalued. The stock's GF Value™ is A$1.76, compared to a current price of A$1.25 — trading 29.3% below its estimated fair value. The current 9-Day RSI is 51.61 and 14.7% below the Insurance industry median of 60.52. Nobleoak Life's overall GF Score™ is 54/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For Nobleoak Life (ASX:NOL), the current 9-Day RSI is 51.61 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nobleoak Life (ASX:NOL) Overvalued in 2026?
Based on GuruFocus' analysis, Nobleoak Life stock appears to be undervalued.
The current stock price of A$1.25 is trading 29.3% below its estimated GF Value™ of A$1.76.
GuruFocus considers Nobleoak Life to be Modestly Undervalued.
Key valuation signals for ASX:NOL:
9-Day RSI: 51.61
GF Value™: A$1.76 vs. price of A$1.25 (29.3% below fair value)
Industry Position: 14.7% below the Insurance median (#210 of 593)
No single metric tells the full story. See the ASX:NOL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nobleoak Life Ltd is involved in the manufacture and distribution of Life Insurance products (including death, total and permanent disability, trauma, income protection and business expenses insurance) through both its Direct and Strategic Partner (Advised) channels. The company's segments include Direct Business, Strategic Partnerships, and Genus. It generates maximum revenue from the Direct segment.
54GF Score
Get the complete analysis for ASX:NOL
9-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:NOL has been successfully added to your 